Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Commercial Business Strategies India

100 Years In India – GSK’s Secret Sauce To Not Just Stay Relevant But Thrive

  • Interviews

Executive Summary

GlaxoSmithKline Pharmaceuticals’ MD tells Scrip how the company has been able to reinvent itself, contemporize brands and get supply chain innovation right as the UK-headquartered firm marks 100 years of operations in India. GSK’s equivalent of the 'Amazon model' for vaccine ordering and the new temples of industry are some of the other facets the executive discussed in the first instalment of this two-part interview. 

Table

View full table

Related Content

Scrip

Topics

Related Companies

Tags:
Commercial Business Strategies India
Latest Headlines

AbbVie’s Tavapadon Demonstrates Efficacy In Parkinson’s Monotherapy Study

Pfizer Withdraws Oxbryta, But Overall Market Impact May Be Limited

REGENCY Dandy for Roche In Lupus Nephritis

Another Miss For LAG-3 In MSS Colorectal Cancer In Keytruda Combo Study

See All
UsernamePublicRestriction

Register

SC150921

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By